Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy. (October 2019) - Çelik, S.; Güven, Z.; Kaynar, L.; Eser, B.; Çetin, M.; Ünal, A.